Diagnostic difficulty in a patient with recurrent attacks of acute polyneuropathy: Acute intermittent porphyria
Öz
Acute intermittent porphyria is one of the most common porphyria subtypes. There is a critical need to diagnose porphyria, given its multisystem nature and the poor prognosis associated with incurable cases. Here we present the case of a 27-year-old female patient who had severe abdominal pain and who was operated on due to ileus with tetraparesis that manifested following an operation. The patient had muscle weakness in four limbs and symptoms of sympathetic hyperactivity and electrolyte imbalance. Moreover, neurophysiological studies supported acute axonal polyneuropathy. Owing to the neurological symptoms, electrophysiological studies, metabolic disorders, and the severe abdominal pain noted, porphyria was suspected. Porphobilinogen and ALA levels increased in the 24-hour urine test, and the patient was diagnosed with acute intermittent porphyria. In patients who have unexplained recurrent abdominal pain with additional autonomic dysfunction, neurological and / or psychiatric findings, porphyria, a rare disease, should come to mind.
Anahtar Kelimeler
Porphyria, acute intermittent porphyria, acute polyneuropathy, motor axonal polyneuropathy
Kaynakça
- 1. Stölzel U, Doss MO, Schuppan D. Clinical Guide and Update on Porphyrias. Gastroenterology. 2019; 157:365-381.e4.
- 2. Ramanujam VMS, Anderson KE. Porphyria diagnostics-part 1: A brief overview of the porphyrias. Current Protocols in Human Genetics. 2015; 17.20.1-17.20.26.
- 3. Spiritos Z, Salvador S, Mosquera D, Wilder J. Acute intermittent porphyria: Current perspectives and case presentation. Therapeutics and Clinical Risk Management. 2019; 15:1443–1451.
- 4. Whatley SD, Mason NG, Woolf JR, Newcombe RG, Elder GH, Badminton MN. Diagnostic strategies for autosomal dominant acute porphyrias: Retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene. Clinical Chemistry. 2009; 55:1406–1414.
- 5. Whatley SD, Badminton MN. Role of genetic testing in the management of patients with inherited porphyria and their families. Annals of Clinical Biochemistry.2013; 50:204–216.
- 6. Bonkovsky HL, Guo JT, Hou W, Li T, Narang T, Thapar M. Porphyrin and heme metabolism and the porphyrias. Comprehensive Physiology.2013; 3:365–401. 7. Simon NG, Herkes GK. The neurologic manifestations of the acute porphyrias. Journal of Clinical Neuroscience. 2011; 18:1147–1153.
- 8. Balwani M, Desnick RJ. The porphyrias: advances in diagnosis and treatment. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2012; 2012:19–27.
- 9. Balwani M, Wang B, Anderson KE, Bloomer JR, Bissell DM, Bonkovsky HL, et al. Acute hepatic porphyrias: Recommendations for evaluation and long-term management. Hepatology. 2017; 66:1314–1322.
- 10. Tracy JA, Dyck PJB. Porphyria and Its Neurologic Manifestations. Vol 120. 1st ed. Elsevier B.V., 2014. http://dx.doi.org/10.1016/B978-0-7020-4087-0.00056-5.
- 11. April M. Scientific Papers Presented at the 52nd Annual Session The American College of Physicians. 2013; 2:817–844.
